BioAffinity Technologies: Jamie Platt
BioAffinity Technologies has appointed Jamie Platt to its board of directors, effective Dec. 1. Currently, she is CEO and Managing Director of New Zealand-based IVD firm Pictor, as well as president and CEO of BridGenomics, a consulting and contracting commercialization company providing molecular and genomics-based advice. Prior to that, Platt was COO of Personal Genomice Diagnostics, now part of Laboratory Corporation of America, as well as COO of Inivata, which was acquired by NeoGenomics. She began her career at Quest Diagnostics where she became VP of genomic solutions at Molecular Pathology Laboratory Network.